Cardinal Health Inc. (CAH) exhibits 3.7% gross margins and 29.7% return on invested capital within Health Care (Other Pharmaceuticals), balanced against a 24.5x enterprise multiple and 4.8% implied options volatility.
Sustained 3.7% gross profitability converts into 1.0% operating margin and 29.7% ROIC, outpacing sector cost of capital.
ROIC: 29.7% // GM: 3.7%YoY revenue trajectory of -1.9% paired with 3.18% free cash flow yield supports self-funded R&D and capital return.
REV YOY: -1.9% // FCF YLD: 3.18%Altman Z-Score of 5.16 and Piotroski F-Score of 6/9 indicate low near-term refinancing stress.
ALTMAN Z: 5.16 // F-SCORE: 6/9Trading at 37.2x trailing P/E (34.6x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 37.2x // EV/EBITDA: 24.5xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $250.48 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Other Pharmaceuticals require continuous execution to defend 0.7% net margins.
NET MARGIN: 0.7% // D/E: 0.85x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for CAH & activate live FRED threshold breach alerts.